Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Nachega: Adherence to nonnucleoside reverse transcriptase inhibitor based HIV therapy and.... (0.09 sec) 

Adherence to nonnucleoside reverse transcriptase inhibitor based HIV therapy and …

- annals.org [PDF] 
JB Nachega, M Hislop, DW Dowdy, RE … - Annals of internal medicine, 2007 - Am Coll Physicians
Background: Adherence of 95% or more to unboosted protease regimens is required
for optimal virologic suppression in HIV-1– infected patients. Whether the
same is true for nonnucleoside re- verse transcriptase inhibitor ...
Cited by 59 - Related articles - BL Direct - All 5 versions

Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and …

- nih.gov
ML Petersen, Y Wang, MJ van der Laan, D … - Clinical Infectious Diseases, 2007 - UChicago Press
Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ...
Cited by 25 - Related articles - BL Direct - All 8 versions

A randomized study of serial telephone call support to increase adherence and thereby …


AC Collier, H Ribaudo, AL Mukherjee, J … - The Journal of infectious diseases, 2005 - UChicago Press
Featured in US News & World Report "Common Cold Virus Alters Body's Genes"
October 24, 2008 Comparison of the Safety and Immunogenicity of 2 Respiratory
Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine ...
Cited by 23 - Related articles - BL Direct - All 4 versions

Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts …


JB Nachega, M Hislop, DW Dowdy, M Lo, SB … - JAIDS Journal of Acquired Immune Deficiency …, 2006 - journals.lww.com
From the Departments of *International Health and ‡Epidemiology, Johns Hopkins
University, Bloomberg School of Public Health; §Department of Medicine,
Division of Infectious Diseases, Johns Hopkins University, School of ...
Cited by 50 - Related articles - BL Direct - All 9 versions

Sustained benefit from a long-term antiretroviral adherence intervention: results of a large …


SB Mannheimer, E Morse, JP Matts, L Andrews, … - JAIDS Journal of Acquired Immune Deficiency …, 2006 - journals.lww.com
Sharon B. Mannheimer, MD,* Edward Morse, PhD,† John P. Matts, PhD,‡ Laurie
Andrews, RN, MPH,§ Carroll Child, RN, MSc,k Barry Schmetter, BS,¶ and Gerald
H. Friedland, MD§ for the Terry Beirn Community Programs for Clinical ...
Cited by 34 - Related articles - BL Direct - All 5 versions

Once-daily nevirapine dosing: a pharmacokinetics, efficacy and safety review


CL Cooper, RPG van Heeswijk - HIV medicine, 2007 - interscience.wiley.com
In the context of attempts to simplify treatment regimens and enhance adherence,
there is great interest in once-daily dosing regimens for the treatment of HIV-1
infection. Nevirapine has a long half-life and achieves high steady-state ...
Cited by 15 - Related articles - BL Direct - All 3 versions

[CITATION] UK HIV drug resistance database: background and recent outputs.


D Dunn, D Pillay - Journal of HIV therapy, 2007 - ncbi.nlm.nih.gov
1: J HIV Ther. 2007 Dec;12(4):97-8. UK HIV drug resistance database: background
and recent outputs. Dunn D, Pillay D. MRC Clinical Trials Unit, London, UK. ...
Cited by 10 - Related articles - BL Direct

[CITATION] Efficacy and safety of fosamprenavir/ritonavir in PI-experienced subjects with virological …


E DeJesus, A LaMarca, M Sension… - 10th Conference on Retroviruses and Opportunistic …
Cited by 10 - Related articles

[CITATION] Simplified PRotease INhibitor Trial (SPRINT): Antiviral effect of once daily saquinavir SGC plus …


J Montaner, N Press, M Harris… - 15th International AIDS Conference
Cited by 10 - Related articles

Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: a …


SD Portsmouth, J Osorio, K McCormick, BG … - HIV medicine, 2005 - interscience.wiley.com
A 24-week randomized open-label simplification study of twice-daily regimens
based on stavudine immediate release or zidovudine to an all once-daily regimen
based on the stavudine prolonged-release capsule (PRC), in persons with ...
Cited by 37 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google